Rein Therapeutics draws attention after director Josef Von Rickenbach buys nearly $50,000 in company shares.
Insider Trading
Table of Contents
May 29, 2026
Rein Therapeutics, Inc. (NASDAQ: RNTX) disclosed that director Josef H. Von Rickenbach purchased company shares across four May transactions, according to a Form 4 filing with the U.S. Securities and Exchange Commission (SEC).
The purchases totaled 47,060 shares for approximately $49,600. The transactions occurred between May 21 and May 27 at prices ranging from $1.04 to $1.07 per share.
After the latest reported purchase, Von Rickenbach owned 62,514 shares directly.
Rein Therapeutics is a biotechnology company focused on developing therapies for serious diseases with high unmet medical need.
The purchase is notable because Von Rickenbach bought shares across multiple trading days rather than making a single isolated purchase.
The buying included 3,420 shares on May 21, 15,950 shares on May 22, 23,190 shares on May 26, and 4,500 shares on May 27.
That pattern shows continued accumulation over several sessions.
The total purchase value was approximately $49,600, which is below the typical $500,000 to $1 million insider-buying threshold often viewed as a stronger signal of executive confidence.
That does not make the purchase irrelevant, but it does lower the signal strength compared with larger CEO, CFO, or clustered insider buying activity.
Smaller insider purchases can carry more weight in small-cap or microcap companies, especially when the buyer increases ownership across several transactions.
In this case, the director’s direct holdings rose from 18,874 shares after the first purchase to 62,514 shares after the latest reported transaction.
That represents a meaningful increase in share ownership, even though the dollar value remains modest.
Insider buying is generally more meaningful when it involves senior executives, larger dollar amounts, repeated purchases, or multiple insiders buying within a short period.
Platforms like LevelFields aggregate insider transactions and flag when activity exceeds key thresholds, helping investors identify when insider buying has historically aligned with meaningful stock movements.
Join LevelFields now to be the first to know about events that affect stock prices and uncover unique investment opportunities. Choose from events, view price reactions, and set event alerts with our AI-powered platform. Don't miss out on daily opportunities from 6,300 companies monitored 24/7. Act on facts, not opinions, and let LevelFields help you become a better investor.

AI scans for events proven to impact stock prices, so you don't have to.
LEARN MORE